Printed from Voxsanity (voxsanity.com.au) — NCT06999330 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Parkinsons Disease
Parkinson's Disease Trial, By Invitation
NCT06999330
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with Idiopathic (no known cause) Parkinson's disease, confirmed by a specialist in movement disorders, with the key symptom of slowness of movement plus at least one of: resting tremor or muscle stiffness.
- People who have anxiety related to Parkinson's disease, based on a score of 14 or higher on the Parkinson's Anxiety Scale (PAS).
- People whose Parkinson's disease is rated at stage 3 or below on the Hoehn & Yahr scale, which measures how advanced the condition is.
- People who score 18 or higher on the MoCA, a standard test used to assess thinking and memory.
- People aged between 40 and 90 years old.
- Women who are post-menopausal, or who return a negative pregnancy test before joining.
- People who are fluent in speaking, reading, and understanding English, as required by the study procedures.
- People who have given written informed consent before taking part; if a person is unable to consent due to cognitive decline, a legally authorised representative may provide consent on their behalf.
- People who have been on a stable dose of Parkinson's medications for at least one month before the first study visit, and who are willing to keep that dose unchanged throughout the study; people taking antidepressant or anti-anxiety medications must also have been on a stable dose for at least one month.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are unable to tolerate medical imaging, or who have implants or metal in their body that make imaging unsafe, including those with a deep brain stimulation device.
- People who have a seizure disorder, or a current problem with alcohol or substance use.
- People who are unable to speak and read English.
- People who, in the opinion of the lead clinician, would be at increased risk or would be unable to fully complete the study for any reason.
- People whose Parkinson's-like symptoms are caused by something other than idiopathic Parkinson's disease, such as certain medications (e.g., metoclopramide or antipsychotics), metabolic or genetic conditions (e.g., Wilson's Disease), brain infections, stroke-related brain disease, or other degenerative conditions (e.g., Progressive Supranuclear Palsy, Multiple System Atrophy, Corticobasal Degeneration, or Lewy Body dementia).
- People who have an advanced form of dementia, including Parkinson's disease dementia or Alzheimer's disease, or who score below 18 on the MoCA thinking and memory test.
- People with a history of moderate to severe lung disease, poorly controlled heart failure, a significant heart or stroke event in the past 6 months, or any other health condition that the investigator considers a safety concern.
- People with a history of a psychiatric illness that the investigator considers a safety risk.
- People who are currently taking sedative medications that the investigator considers to be a clinical concern in the context of this study.
- People who have had a change in their Parkinson's, antidepressant, or anti-anxiety medications within one month before their first study visit.
- People who are considered a safety risk by the investigator for any reason.
- People who have taken part in another clinical trial within the past 3 months.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
By Invitation
Phase
Not Applicable
Sponsor
HealthPartners Institute
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
31 December 2027
Where this trial is recruiting
🇺🇸 United States
Primary endpoints
Recruitment Rate; Participation Rate; Fidelity; Completion Rate; Adverse Events Rate - Safety; Adverse Events Safety
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.